NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE247277 Query DataSets for GSE247277
Status Public on Nov 08, 2023
Title Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults [scRNA-seq]
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Pneumococcal infections cause serious illness and death among older adults. A capsular polysaccharide vaccine PPSV23 (Pneumovax®) and a conjugated polysaccharide vaccine PCV13 (Prevnar®) are used to prevent these infections, yet underlying immunological responses, and baseline predictors remain unknown. We recruited and vaccinated 39 older adults (>60 years) with PPSV23 or PCV13. Both vaccines induced strong antibody responses at day 28 and similar plasmablast transcriptional signatures at day 10, however, their baseline predictors were distinct. Analyses of baseline flow cytometry and RNA-seq data (bulk and single cell) revealed a novel baseline phenotype that is specifically associated with weaker PCV13 responses, characterized by i) increased expression of cytotoxicity-associated genes and increased CD16+ NK frequency; ii) increased Th17 and decreased Th1 cell frequency. Men were more likely to display this cytotoxic phenotype and mounted weaker responses to PCV13 than women. Baseline expression levels of a distinct gene set was predictive of PPSV23 responses. This first precision vaccinology study for pneumococcal vaccine responses of older adults uncovered novel and distinct baseline predictors that might transform vaccination strategies and initiate novel interventions.
 
Overall design Our study involved the single-cell RNA sequencing (scRNA-seq) profiling of peripheral blood mononuclear cells (PBMCs) obtained from 11 donors before PCV13 vaccination. Among these donors, six are strong responders (SR) to PCV13, and five are weak responders (WR).
***Submitter declares that the raw data will be available through dbGAP (phs002361) due to patient privacy concerns***
Web link https://www.nature.com/articles/s41590-023-01717-5
 
Contributor(s) Ucar D, Ravichandran S
Citation(s) 38182669
NIH grant(s)
Grant ID Grant title Affiliation Name
R01 AG052608 Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines THE JACKSON LABORATORY Jacques F Banchereau
P30 AG067988 Claude D. Pepper Older Americans Independence Center (P30 Clinical Trial Optional) UNIVERSITY OF CONNECTICUT HEALTH CENTER George A Kuchel
U01 AI165452 A deep longitudinal analysis of next generation influenza vaccines in older adults THE JACKSON LABORATORY George A Kuchel
R01 AI142086 High-resolution single cell profiling of vaccine responsiveness in the elderly THE JACKSON LABORATORY Duygu Ucar
Submission date Nov 08, 2023
Last update date Jan 08, 2024
Contact name Duygu Ucar
E-mail(s) duygu.ucar@jax.org
Organization name The Jackson laboratory for Genomic Medicine
Street address 10 Discovery Dr
City Farmington
State/province CT
ZIP/Postal code 06032
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (11)
GSM7886593 PBMC, Baseline, Strong Responder (SR), PREV10
GSM7886594 PBMC, Baseline, Strong Responder (SR), PREV18
GSM7886595 PBMC, Baseline, Weak Responder (WR), PREV23
Relations
BioProject PRJNA1037044

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE247277_RAW.tar 388.9 Mb (http)(custom) TAR (of MTX, TSV)
Raw data not provided for this record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap